Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/25 16:16 | 9/16/25 | FTRE | Health | Health | Medical Laboratories | Parks Robert | NC | O | Chief Ac | 2 | S.d | -79 | 9.97 | 0 | -8 | 19 | D | |||||||||||||||
9/10/25 16:34 | 9/9/25 | FTRE | Health | Health | Medical Laboratories | Hanson James S. | NC | O | GC | 3 | S.d | -36 | 7.40 | 0 | -5 | 19 | D | |||||||||||||||
9/10/25 16:32 | 9/9/25 | FTRE | Health | Health | Medical Laboratories | Morais Mark A. | NC | O | COO | 8 | S.d | -121 | 8.46 | 0 | -14 | 62 | D | |||||||||||||||
9/10/25 16:30 | 9/9/25 | FTRE | Health | Health | Medical Laboratories | McConnell Jill G. | NC | O | CFO | 8 | S.d | -122 | 8.45 | 0 | -14 | 59 | D | |||||||||||||||
1/14/25 18:08 | 1/13/25 | FTRE | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | 1 | S.d | -203 | 18.04 | 0 | -11 | 160 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |